Biblio
“A Depressive Endophenotype for Predicting Cognitive Decline among Mexican American Adults and Elders.”, J Alzheimers Dis, vol. 54, no. 1, pp. 201-6, 2016.
, “Molecular markers of amnestic mild cognitive impairment among Mexican Americans.”, J Alzheimers Dis, vol. 49, no. 1, pp. 221-8, 2016.
, “A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 1, pp. 97-104, 2018.
, “Combining Select Blood-Based Biomarkers with Neuropsychological Assessment to Detect Mild Cognitive Impairment among Mexican Americans.”, J Alzheimers Dis, vol. 75, no. 3, pp. 739-750, 2020.
, “Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome.”, J Alzheimers Dis, vol. 79, no. 2, pp. 671-681, 2021.
, “Characterization of Mild Cognitive Impairment and Dementia among Community-Dwelling Mexican Americans and Non-Hispanic Whites.”, J Alzheimers Dis, vol. 90, no. 2, pp. 905-915, 2022.
, “Metabolic Factors Are Related to Brain Amyloid Among Mexican Americans: A HABS-HD Study.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1745-1750, 2022.
, “Association of Alzheimer's disease biomarkers with low premorbid intellectual functioning in a multi-ethnic community-dwelling cohort: A cross-sectional study of HABS-HD.”, J Alzheimers Dis, p. 13872877251322966, 2025.
,